Clinical Trial Update: Anamorelin Hydrochloride, Physical Activity, and Nutritional Counseling in Decreasing Cancer-Related Fatigue in Patients With Incurable Metastatic or Recurrent Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating anamorelin hydrochloride with physical activity and nutritional counseling to reduce cancer-related fatigue in patients with i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Cachexia
• Cancer-related Fatigue

Drugs mentioned

• Anamorelin hydrochloride (anamorelin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Malignant Solid Neoplasm, C-Reactive Protein Measurement | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2022-02-03